NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-242.32M
↓ 99% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-121.83M
Historical baseline
PeriodValueYoY Change
2025$-242.32M-0.3%
2024$-241.49M-36.5%
2023$-176.86M-691.7%
2022$-22.34M+46.0%
2021$-41.37M-523.9%
2020$-6.63M-